• Clathrin-Mediated Entry of Grass Carp Reovirus: Inhibitor In

  2026-05-20

  Wang et al. (2018) provide compelling evidence that genotype III grass carp reovirus (GCRV104) enters host cells via clathrin-mediated, pH-dependent endocytosis. Their inhibitor-based dissection clarifies viral entry mechanisms, guiding future antiviral research and assay design.

• URB597 (KDS-4103): Selective FAAH Inhibition in Neuroplastic

  2026-05-20

  URB597 (KDS-4103) is a potent, selective FAAH inhibitor used to elevate anandamide levels and dissect endocannabinoid signaling. It enables precise in vivo FAAH inhibition within minutes and shows minimal off-target activity, making it a valuable tool for neuroplasticity and neuroinflammation studies.

• URB597 (KDS-4103): Advanced Insights into FAAH Inhibition an

  2026-05-19

  Explore the unique biochemical properties and advanced research applications of URB597, a selective FAAH inhibitor. This article offers an in-depth analysis of URB597’s mechanism, its distinctions from CBD-based modulation, and its pivotal role in endocannabinoid signaling studies.

• Efficient Recombinant Annexin V Purification for Biophysical

  2026-05-19

  The referenced study introduces a rapid purification protocol for recombinant annexin V, enabling high-purity yields crucial for advanced biophysical analyses. This method leverages calcium-mediated reversible binding and optimized cell lysis, setting a new standard for functional protein preparation in ion channel and structural research.

• Kanamycin Sulfate: Mechanisms, Resistance, and Translational

  2026-05-18

  Explore how Kanamycin Sulfate, a high-purity water-soluble antibiotic, empowers translational research by uniting molecular mechanism, rigorous workflow design, and strategic insight into antibiotic resistance. This article synthesizes mechanistic data, competitive context, and the latest research on microbiota modulation, providing actionable guidance and a forward-looking perspective for microbiologists and translational scientists.

• AZD2461: Novel PARP Inhibitor Accelerates Breast Cancer Rese

  2026-05-18

  AZD2461, a next-generation PARP inhibitor, offers robust cytotoxicity in breast cancer models and uniquely circumvents Pgp-mediated resistance. This article details optimized workflows, troubleshooting strategies, and data-driven use-cases that position AZD2461 as a pivotal tool for DNA repair pathway studies.

• Mechanistic DDI Risk with Oteseconazole: Insights from 2022

  2026-05-17

  This article examines the comprehensive enzyme and transporter-mediated drug-drug interaction (DDI) risk assessment for Oteseconazole (VT-1161), drawing on an FDA-wide analysis of drugs approved in 2022. The findings highlight Oteseconazole's profile as a potent antifungal with specific DDI liabilities, informing both clinical practice and antifungal research workflows.

• Sisomicin’s In Vitro Activity vs. Clinical Bacterial Isolate

  2026-05-16

  This study by Stewart and Bodey systematically evaluates the antimicrobial potency of sisomicin, a newly characterized aminoglycoside, against a broad collection of clinical bacterial isolates. The findings clarify sisomicin’s comparative efficacy, spectrum, and resistance profile, offering mechanistic and benchmarking insights for antibiotic resistance research and microbiology antibiotic studies.

• SB743921: Mechanistic Insights for Advanced Cancer Assay Des

  2026-05-15

  Explore the mechanistic depth of SB743921, a potent kinesin spindle protein inhibitor, and its implications for advanced cancer assay design. This article uniquely bridges mechanistic understanding with practical assay optimization for cancer research.

• SGI-1027 and Everolimus Synergistically Trigger RCC Cell Dea

  2026-05-15

  This study reveals that the DNMT1 inhibitor SGI-1027, when paired with everolimus, induces methuosis and enhances both apoptosis and pyroptosis in renal cell carcinoma by disrupting lysosomal membrane integrity. These findings offer a mechanistic rationale for combination therapies to overcome everolimus resistance in advanced RCC.

• Dimethyloxalylglycine (DMOG): Technical Protocols and Scope

  2026-05-14

  Dimethyloxalylglycine (DMOG) provides a reliable tool for stabilization of hypoxia-inducible factors, enabling controlled studies of hypoxic signaling and immune modulation in vitro and in vivo. It is not appropriate for diagnostic or clinical applications, and its use should be confined to research workflows with clearly defined parameters.

• CHIR-99021 (CT99021) in Neuronal Differentiation: Beyond Plu

  2026-05-14

  Explore how CHIR-99021 (CT99021) enables precise neuronal differentiation via GSK-3 inhibition and Wnt/β-catenin pathway modulation. This in-depth guide uniquely connects molecular action to recent advances in axonogenesis, offering strategic insights for advanced stem cell research.

• Morning Training Enhances Endurance Adaptation in Mice

  2026-05-13

  A recent study demonstrates that endurance training undertaken during the early active (morning) phase in mice yields more rapid and efficient performance adaptations than identical training performed later in the day. These findings underscore the importance of exercise timing in shaping metabolic and physiological responses relevant to endurance and glycogen metabolism research.

• Chloramphenicol in Plasmid Selection: Protocols & Resistance

  2026-05-13

  Chloramphenicol's precise inhibition of bacterial protein synthesis makes it an indispensable tool for stringent plasmid selection and molecular resistance studies. Here, we translate recent advances in carbapenemase gene monitoring and horizontal gene transfer into stepwise workflows and troubleshooting tips, harnessing APExBIO’s high-purity reagent for superior experimental control.

• MOG (35-55): Enhancing Autoimmune Encephalomyelitis Research

  2026-05-12

  MOG (35-55) Peptide from APExBIO enables high-fidelity, reproducible induction of experimental autoimmune encephalomyelitis, the gold-standard model for multiple sclerosis research. This guide delivers actionable protocols, troubleshooting strategies, and advanced insights drawn from recent breakthroughs in neuroinflammation assay design.

16788 records 1/1120 page Next 12345 下5页 Last page